Yüklüyor......

Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal

In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (C...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Environ Res Public Health
Asıl Yazarlar: Armeni, Patrizio, Cavazza, Marianna, Xoxi, Entela, Taruscio, Domenica, Kodra, Yllka
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908548/
https://ncbi.nlm.nih.gov/pubmed/33530652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph18031101
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!